ARCHIVES

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

This article is from The Cancer Letter archive.

Vol. 09 No. 09 | March 4, 1983

Download PDF Visit The Full Archive

Related Articles

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

PDF file includes 8-page February issue of Business & Regulatory Report.

February 27, 2004

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

Georgetown Names Cullen Interim Center Director.

November 3, 2000

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997